Immune dysregulation and <scp>RNA N6</scp> ‐methyladenosine modification in sepsis-Reference-Cited by-同舟云学术

Immune dysregulation and RNA N6 ‐methyladenosine modification in sepsis

Published:2022-09-23 Issue: Volume: Page:
ISSN:1757-7004
Container-title:WIREs RNA
language:en
Short-container-title:WIREs RNA

Author:

Chen Hongyan¹²³⁴,Zhang Xiaoting¹²³⁴,Su Hao¹²³⁴,Zeng Judeng¹²³,Chan Hung¹²³,Li Qing¹²³⁴,Liu Xiaodong¹²³,Zhang Lin¹²³⁴,Wu William Ka Kei¹²³⁴,Chan Matthew Tak Vai¹²³^ORCID,Chen Huarong¹²³⁴^ORCID

Affiliation:

1. Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute The Chinese University of Hong Kong Hong Kong China

2. CUHK Shenzhen Research Institute Shenzhen Guangdong China

3. Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China

4. State Key Laboratory of Digestive Diseases The Chinese University of Hong Kong Hong Kong China

Funder

Health and Medical Research Fund

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wrna.1764

Reference152 articles.

1. Natural Killer Cells: Development, Maturation, and Clinical Utilization

2. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression

3. Critical care and the global burden of critical illness in adults

4. Current and Projected Workforce Requirements for Care of the Critically Ill and Patients With Pulmonary DiseaseCan We Meet the Requirements of an Aging Population?

5. Metabolic regulation of immune responses: therapeutic opportunities

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

2. Post-translational modifications in sepsis-induced organ dysfunction: mechanisms and implications;Frontiers in Immunology;2024-08-21

3. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification;Cancer Gene Therapy;2024-06-04

4. METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway;2024-01-10

5. METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway;International Journal of Medical Sciences;2024